Custom crystal celebrating FDA acceptance of the Investigational Drug Application for XTX101, a potential treatment for cancer patients.
(21AJH115)
The Corporate Presence has designed commemoratives for launches ranging from software to podcasts to FDA-approved drugs and treatments; and for openings ranging from college buildings to wind farms to Broadway musicals.
Custom crystal celebrating FDA acceptance of the Investigational Drug Application for XTX101, a potential treatment for cancer patients.
(21AJH115)Custom Lucite, with an embedded drug vial, celebrating FDA approval of Cosela. (20ADH005)
Custom crystal celebrating the launch by fintech firm Bakkt of its digital wallet app.
(21AKL105)Crystal deal toy celebrating the opening by Florida Power & Light of four solar power plants.
(9AKL566)Custom crystal and wood commemorative celebrating the founding of Uneti Ventures, a venture capital firm focused on finTech, greenTech, and medTech.
(21LSS194)Custom Lucite commemorating the opening night on Broadway of the musical “Hadestown”.
(9AKL175)Custom crystal commemorating groundbreaking for a levee improvement project undertaken by Foster City, California.
(20ALJ322)Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis.
(9AMF149)Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)
